Selected exits

ActivX Biosciences, Inc.

ActivX Biosciences, Inc. was acquired by Kyorin Pharmaceutical Co., Ltd. in 2004.

Amira Pharmaceuticals, Inc.

Amira Pharmaceuticals was acquired by Bristol-Myers Squibb in 2011.

Arakis Ltd.

Arakis Ltd. was acquired by Sosei Co. Ltd. in 2005.

Arpida Ltd.

Arpida Ltd. was focused on the development of novel antibiotic drugs.

Cabrellis Pharmaceuticals Corp.

Cabrellis Pharmaceuticals Corp. was acquired by Pharmion Corporation in 2006.

Combio A/S

CombioA/S was acquired by Arpida Ltd. in 2004.

Conforma Therapeutics Corp.

Conforma Therapeutics Corp. was acquired by Biogen Idec in 2006.

Corus Pharma, Inc.

Corus Pharma, Inc. was acquired by Gilead Sciences, Inc. in 2006.

FoldRx Pharmaceuticals, Inc.

FoldRx Pharmaceuticals, Inc. was acquired by Pfizer Inc. in 2010.

Gloucester Pharmaceuticals

Gloucester Pharmaceuticals was acquired by Celgene Corporation in 2010

InSound Medical, Inc.

InSound Medical, Inc. was acquired by Sonova Holding AG in 2010.

Neurodan A/S

Neurodan A/S was acquired by Otto Bock GmbH in 2005.

Novexel S.A.

Novexel S.A. was acquired by AstraZeneca in 2010.

Panacos Pharmaceuticals, Inc.

Panacos Pharmaceuticals, Inc. developed small molecule drugs against infectious disease.

Protein Forest, Inc.

Protein Forest Inc. was acquired by ProteinSimple Inc. in 2009.

Salmedix, Inc.

Salmedix, Inc. was acquired by Cephalon, Inc. in 2005.

Sapphire Therapeutics, Inc.

Sapphire Therapeutics, Inc. was acquired by Helsinn S.A. in 2009.

Sosei Co. Ltd.

Sosei Co. Ltd. acquired Arakis Ltd. in 2005.

Synosia Therapeutics

Synosia was acquired by Biotie Therapies Corporation in 2011.

Thiakis Ltd.

Thiakis, Ltd. was acquired by Wyeth Pharmaceuticals in 2008.

ZymoGenetics, Inc.

ZymoGenetics, Inc. was acquired by Bristol-Myers Squibb in 2010.